Chembio Diagnostics (NASDAQ:CEMI) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance Shares of NASDAQ CEMI opened at $0.46 on Friday. Chembio Diagnostics has a 52-week low of $0.19 and a 52-week high of $1.24. The […]

Related Keywords

,Chembio Diagnostics Company Profile ,York Mellon Corp ,Chembio Diagnostics Inc ,Renaissance Technologies ,Vanguard Group Inc ,Chembio Diagnostics ,Get Rating ,Advisors Ll Perceptive ,New York Mellon Corp ,Vanguard Group ,Chembio Diagnostics Daily ,Nasdaq Cemi ,Acemi ,Medical ,Initiated Coverage ,Stocknews Com ,